The global Discovery Biology Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

Discovery Biology Service is an outsourcing service designed to support pharmaceutical companies, biotechnology companies and academic research institutions in the process of drug discovery and development, through in vitro or in vivo experiments, molecular and cell biology techniques, and other methods to conduct early drug screening, target validation, mechanism research, and drug activity and toxicity evaluation. These services help accelerate the process of drug discovery, improve research efficiency, and reduce costs.

The Discovery Biology Service market is growing rapidly, mainly driven by the increasing demand for outsourcing in the biopharmaceutical industry. Pharmaceutical and biotechnology companies are increasingly relying on professional technical support and resources provided by external service providers in the face of increasingly complex drug development challenges and strict regulatory requirements. This trend is most significant in North America and Europe, and the Asia-Pacific region is also rapidly emerging as an important force in the global biology services market. With the continuous emergence of new technologies and the rise of precision medicine, this market is expected to continue to expand.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Discovery Biology Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Discovery Biology Service Market Report

Report Metric	Details
Report Name	Discovery Biology Service Market
Segment by Type	Drug Screening Services Target Validation Services Mechanism of Action Studies Others
Segment by Application	Drug Development Biological Research Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River Laboratories, Eurofins Advinus, Jubilant Biosys, Syngene, BioDuro-Sundia, Aurigene Pharmaceutical Services, Anthem Biosciences, Sai Life Sciences, Pharma Inventor, Strateos, TheraIndx, ChemDiv, Curia Global, BPS Bioscience, WuXi Biology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Discovery Biology Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Discovery Biology Service Market report?

Ans: The main players in the Discovery Biology Service Market are Charles River Laboratories, Eurofins Advinus, Jubilant Biosys, Syngene, BioDuro-Sundia, Aurigene Pharmaceutical Services, Anthem Biosciences, Sai Life Sciences, Pharma Inventor, Strateos, TheraIndx, ChemDiv, Curia Global, BPS Bioscience, WuXi Biology

What are the Application segmentation covered in the Discovery Biology Service Market report?

Ans: The Applications covered in the Discovery Biology Service Market report are Drug Development, Biological Research, Others

What are the Type segmentation covered in the Discovery Biology Service Market report?

Ans: The Types covered in the Discovery Biology Service Market report are Drug Screening Services, Target Validation Services, Mechanism of Action Studies, Others

1 Study Coverage

1.1 Introduction to Discovery Biology Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Discovery Biology Service Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Drug Screening Services

1.2.3 Target Validation Services

1.2.4 Mechanism of Action Studies

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Discovery Biology Service Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Drug Development

1.3.3 Biological Research

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Discovery Biology Service Revenue Estimates and Forecasts 2020-2031

2.2 Global Discovery Biology Service Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Discovery Biology Service Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Discovery Biology Service Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Drug Screening Services Market Size by Players

3.3.2 Target Validation Services Market Size by Players

3.3.3 Mechanism of Action Studies Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global Discovery Biology Service Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Discovery Biology Service Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Discovery Biology Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Discovery Biology Service Market Size by Type (2020-2031)

6.4 North America Discovery Biology Service Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Discovery Biology Service Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Discovery Biology Service Market Size by Type (2020-2031)

7.4 Europe Discovery Biology Service Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Discovery Biology Service Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Discovery Biology Service Market Size by Type (2020-2031)

8.4 Asia-Pacific Discovery Biology Service Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Discovery Biology Service Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Discovery Biology Service Market Size by Type (2020-2031)

9.4 Central and South America Discovery Biology Service Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Discovery Biology Service Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Discovery Biology Service Market Size by Type (2020-2031)

10.4 Middle East and Africa Discovery Biology Service Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Discovery Biology Service Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Charles River Laboratories

11.1.1 Charles River Laboratories Corporation Information

11.1.2 Charles River Laboratories Business Overview

11.1.3 Charles River Laboratories Discovery Biology Service Product Features and Attributes

11.1.4 Charles River Laboratories Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.1.5 Charles River Laboratories Discovery Biology Service Revenue by Product in 2024

11.1.6 Charles River Laboratories Discovery Biology Service Revenue by Application in 2024

11.1.7 Charles River Laboratories Discovery Biology Service Revenue by Geographic Area in 2024

11.1.8 Charles River Laboratories Discovery Biology Service SWOT Analysis

11.1.9 Charles River Laboratories Recent Developments

11.2 Eurofins Advinus

11.2.1 Eurofins Advinus Corporation Information

11.2.2 Eurofins Advinus Business Overview

11.2.3 Eurofins Advinus Discovery Biology Service Product Features and Attributes

11.2.4 Eurofins Advinus Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.2.5 Eurofins Advinus Discovery Biology Service Revenue by Product in 2024

11.2.6 Eurofins Advinus Discovery Biology Service Revenue by Application in 2024

11.2.7 Eurofins Advinus Discovery Biology Service Revenue by Geographic Area in 2024

11.2.8 Eurofins Advinus Discovery Biology Service SWOT Analysis

11.2.9 Eurofins Advinus Recent Developments

11.3 Jubilant Biosys

11.3.1 Jubilant Biosys Corporation Information

11.3.2 Jubilant Biosys Business Overview

11.3.3 Jubilant Biosys Discovery Biology Service Product Features and Attributes

11.3.4 Jubilant Biosys Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.3.5 Jubilant Biosys Discovery Biology Service Revenue by Product in 2024

11.3.6 Jubilant Biosys Discovery Biology Service Revenue by Application in 2024

11.3.7 Jubilant Biosys Discovery Biology Service Revenue by Geographic Area in 2024

11.3.8 Jubilant Biosys Discovery Biology Service SWOT Analysis

11.3.9 Jubilant Biosys Recent Developments

11.4 Syngene

11.4.1 Syngene Corporation Information

11.4.2 Syngene Business Overview

11.4.3 Syngene Discovery Biology Service Product Features and Attributes

11.4.4 Syngene Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.4.5 Syngene Discovery Biology Service Revenue by Product in 2024

11.4.6 Syngene Discovery Biology Service Revenue by Application in 2024

11.4.7 Syngene Discovery Biology Service Revenue by Geographic Area in 2024

11.4.8 Syngene Discovery Biology Service SWOT Analysis

11.4.9 Syngene Recent Developments

11.5 BioDuro-Sundia

11.5.1 BioDuro-Sundia Corporation Information

11.5.2 BioDuro-Sundia Business Overview

11.5.3 BioDuro-Sundia Discovery Biology Service Product Features and Attributes

11.5.4 BioDuro-Sundia Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.5.5 BioDuro-Sundia Discovery Biology Service Revenue by Product in 2024

11.5.6 BioDuro-Sundia Discovery Biology Service Revenue by Application in 2024

11.5.7 BioDuro-Sundia Discovery Biology Service Revenue by Geographic Area in 2024

11.5.8 BioDuro-Sundia Discovery Biology Service SWOT Analysis

11.5.9 BioDuro-Sundia Recent Developments

11.6 Aurigene Pharmaceutical Services

11.6.1 Aurigene Pharmaceutical Services Corporation Information

11.6.2 Aurigene Pharmaceutical Services Business Overview

11.6.3 Aurigene Pharmaceutical Services Discovery Biology Service Product Features and Attributes

11.6.4 Aurigene Pharmaceutical Services Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.6.5 Aurigene Pharmaceutical Services Recent Developments

11.7 Anthem Biosciences

11.7.1 Anthem Biosciences Corporation Information

11.7.2 Anthem Biosciences Business Overview

11.7.3 Anthem Biosciences Discovery Biology Service Product Features and Attributes

11.7.4 Anthem Biosciences Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.7.5 Anthem Biosciences Recent Developments

11.8 Sai Life Sciences

11.8.1 Sai Life Sciences Corporation Information

11.8.2 Sai Life Sciences Business Overview

11.8.3 Sai Life Sciences Discovery Biology Service Product Features and Attributes

11.8.4 Sai Life Sciences Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.8.5 Sai Life Sciences Recent Developments

11.9 Pharma Inventor

11.9.1 Pharma Inventor Corporation Information

11.9.2 Pharma Inventor Business Overview

11.9.3 Pharma Inventor Discovery Biology Service Product Features and Attributes

11.9.4 Pharma Inventor Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.9.5 Pharma Inventor Recent Developments

11.10 Strateos

11.10.1 Strateos Corporation Information

11.10.2 Strateos Business Overview

11.10.3 Strateos Discovery Biology Service Product Features and Attributes

11.10.4 Strateos Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 TheraIndx

11.11.1 TheraIndx Corporation Information

11.11.2 TheraIndx Business Overview

11.11.3 TheraIndx Discovery Biology Service Product Features and Attributes

11.11.4 TheraIndx Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.11.5 TheraIndx Recent Developments

11.12 ChemDiv

11.12.1 ChemDiv Corporation Information

11.12.2 ChemDiv Business Overview

11.12.3 ChemDiv Discovery Biology Service Product Features and Attributes

11.12.4 ChemDiv Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.12.5 ChemDiv Recent Developments

11.13 Curia Global

11.13.1 Curia Global Corporation Information

11.13.2 Curia Global Business Overview

11.13.3 Curia Global Discovery Biology Service Product Features and Attributes

11.13.4 Curia Global Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.13.5 Curia Global Recent Developments

11.14 BPS Bioscience

11.14.1 BPS Bioscience Corporation Information

11.14.2 BPS Bioscience Business Overview

11.14.3 BPS Bioscience Discovery Biology Service Product Features and Attributes

11.14.4 BPS Bioscience Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.14.5 BPS Bioscience Recent Developments

11.15 WuXi Biology

11.15.1 WuXi Biology Corporation Information

11.15.2 WuXi Biology Business Overview

11.15.3 WuXi Biology Discovery Biology Service Product Features and Attributes

11.15.4 WuXi Biology Discovery Biology Service Revenue and Gross Margin (2020-2025)

11.15.5 WuXi Biology Recent Developments

12 Discovery Biology ServiceIndustry Chain Analysis

12.1 Discovery Biology Service Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Discovery Biology Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Discovery Biology Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Charles River Laboratories

Aurigene Pharmaceutical Services

List of Tables

Table 1. Global Discovery Biology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Discovery Biology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Discovery Biology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Discovery Biology Service Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Discovery Biology Service Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Discovery Biology Service Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Discovery Biology Service Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Discovery Biology Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Discovery Biology Service as of 2024)

Table 11. Global Discovery Biology Service Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Discovery Biology Service Companies Headquarters

Table 13. Global Discovery Biology Service Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Discovery Biology Service Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Discovery Biology Service Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Discovery Biology Service Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Discovery Biology Service Revenue by Application (2026-2031) & (US$ Million)

Table 21. Discovery Biology Service High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Discovery Biology Service Growth Accelerators and Market Barriers

Table 25. North America Discovery Biology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Discovery Biology Service Growth Accelerators and Market Barriers

Table 27. Europe Discovery Biology Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Discovery Biology Service Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Discovery Biology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Discovery Biology Service Investment Opportunities and Key Challenges

Table 31. Central and South America Discovery Biology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Discovery Biology Service Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Discovery Biology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Charles River Laboratories Corporation Information

Table 35. Charles River Laboratories Description and Major Businesses

Table 36. Charles River Laboratories Product Features and Attributes

Table 37. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Charles River Laboratories Revenue Proportion by Product in 2024

Table 39. Charles River Laboratories Revenue Proportion by Application in 2024

Table 40. Charles River Laboratories Revenue Proportion by Geographic Area in 2024

Table 41. Charles River Laboratories Discovery Biology Service SWOT Analysis

Table 42. Charles River Laboratories Recent Developments

Table 43. Eurofins Advinus Corporation Information

Table 44. Eurofins Advinus Description and Major Businesses

Table 45. Eurofins Advinus Product Features and Attributes

Table 46. Eurofins Advinus Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Eurofins Advinus Revenue Proportion by Product in 2024

Table 48. Eurofins Advinus Revenue Proportion by Application in 2024

Table 49. Eurofins Advinus Revenue Proportion by Geographic Area in 2024

Table 50. Eurofins Advinus Discovery Biology Service SWOT Analysis

Table 51. Eurofins Advinus Recent Developments

Table 52. Jubilant Biosys Corporation Information

Table 53. Jubilant Biosys Description and Major Businesses

Table 54. Jubilant Biosys Product Features and Attributes

Table 55. Jubilant Biosys Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Jubilant Biosys Revenue Proportion by Product in 2024

Table 57. Jubilant Biosys Revenue Proportion by Application in 2024

Table 58. Jubilant Biosys Revenue Proportion by Geographic Area in 2024

Table 59. Jubilant Biosys Discovery Biology Service SWOT Analysis

Table 60. Jubilant Biosys Recent Developments

Table 61. Syngene Corporation Information

Table 62. Syngene Description and Major Businesses

Table 63. Syngene Product Features and Attributes

Table 64. Syngene Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Syngene Revenue Proportion by Product in 2024

Table 66. Syngene Revenue Proportion by Application in 2024

Table 67. Syngene Revenue Proportion by Geographic Area in 2024

Table 68. Syngene Discovery Biology Service SWOT Analysis

Table 69. Syngene Recent Developments

Table 70. BioDuro-Sundia Corporation Information

Table 71. BioDuro-Sundia Description and Major Businesses

Table 72. BioDuro-Sundia Product Features and Attributes

Table 73. BioDuro-Sundia Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. BioDuro-Sundia Revenue Proportion by Product in 2024

Table 75. BioDuro-Sundia Revenue Proportion by Application in 2024

Table 76. BioDuro-Sundia Revenue Proportion by Geographic Area in 2024

Table 77. BioDuro-Sundia Discovery Biology Service SWOT Analysis

Table 78. BioDuro-Sundia Recent Developments

Table 79. Aurigene Pharmaceutical Services Corporation Information

Table 80. Aurigene Pharmaceutical Services Description and Major Businesses

Table 81. Aurigene Pharmaceutical Services Product Features and Attributes

Table 82. Aurigene Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Aurigene Pharmaceutical Services Recent Developments

Table 84. Anthem Biosciences Corporation Information

Table 85. Anthem Biosciences Description and Major Businesses

Table 86. Anthem Biosciences Product Features and Attributes

Table 87. Anthem Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Anthem Biosciences Recent Developments

Table 89. Sai Life Sciences Corporation Information

Table 90. Sai Life Sciences Description and Major Businesses

Table 91. Sai Life Sciences Product Features and Attributes

Table 92. Sai Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Sai Life Sciences Recent Developments

Table 94. Pharma Inventor Corporation Information

Table 95. Pharma Inventor Description and Major Businesses

Table 96. Pharma Inventor Product Features and Attributes

Table 97. Pharma Inventor Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Pharma Inventor Recent Developments

Table 99. Strateos Corporation Information

Table 100. Strateos Description and Major Businesses

Table 101. Strateos Product Features and Attributes

Table 102. Strateos Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Strateos Recent Developments

Table 104. TheraIndx Corporation Information

Table 105. TheraIndx Description and Major Businesses

Table 106. TheraIndx Product Features and Attributes

Table 107. TheraIndx Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. TheraIndx Recent Developments

Table 109. ChemDiv Corporation Information

Table 110. ChemDiv Description and Major Businesses

Table 111. ChemDiv Product Features and Attributes

Table 112. ChemDiv Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. ChemDiv Recent Developments

Table 114. Curia Global Corporation Information

Table 115. Curia Global Description and Major Businesses

Table 116. Curia Global Product Features and Attributes

Table 117. Curia Global Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. Curia Global Recent Developments

Table 119. BPS Bioscience Corporation Information

Table 120. BPS Bioscience Description and Major Businesses

Table 121. BPS Bioscience Product Features and Attributes

Table 122. BPS Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. BPS Bioscience Recent Developments

Table 124. WuXi Biology Corporation Information

Table 125. WuXi Biology Description and Major Businesses

Table 126. WuXi Biology Product Features and Attributes

Table 127. WuXi Biology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. WuXi Biology Recent Developments

Table 129. Raw Materials Key Suppliers

Table 130. Distributors List

Table 131. Market Trends and Market Evolution

Table 132. Market Drivers and Opportunities

Table 133. Market Challenges, Risks, and Restraints

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Discovery Biology Service Product Picture

Figure 2. Global Discovery Biology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Drug Screening Services Product Picture

Figure 4. Target Validation Services Product Picture

Figure 5. Mechanism of Action Studies Product Picture

Figure 6. Others Product Picture

Figure 7. Global Discovery Biology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Drug Development

Figure 9. Biological Research

Figure 10. Others

Figure 11. Discovery Biology Service Report Years Considered

Figure 12. Global Discovery Biology Service Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 14. Global Discovery Biology Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Discovery Biology Service Revenue Market Share by Region (2020-2031)

Figure 16. Global Discovery Biology Service Revenue Market Share Ranking (2024)

Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 18. Drug Screening Services Revenue Market Share by Player in 2024

Figure 19. Target Validation Services Revenue Market Share by Player in 2024

Figure 20. Mechanism of Action Studies Revenue Market Share by Player in 2024

Figure 21. Others Revenue Market Share by Player in 2024

Figure 22. Global Discovery Biology Service Revenue Market Share by Type (2020-2031)

Figure 23. Global Discovery Biology Service Revenue Market Share by Application (2020-2031)

Figure 24. North America Discovery Biology Service Revenue YoY (2020-2031) & (US$ Million)

Figure 25. North America Top 5 Players Discovery Biology Service Revenue (US$ Million) in 2024

Figure 26. North America Discovery Biology Service Revenue (US$ Million) by Type (2020 - 2031)

Figure 27. North America Discovery Biology Service Revenue (US$ Million) by Application (2020-2031)

Figure 28. US Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 29. Canada Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 30. Mexico Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 31. Europe Discovery Biology Service Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Europe Top 5 Players Discovery Biology Service Revenue (US$ Million) in 2024

Figure 33. Europe Discovery Biology Service Revenue (US$ Million) by Type (2020-2031)

Figure 34. Europe Discovery Biology Service Revenue (US$ Million) by Application (2020-2031)

Figure 35. Germany Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 36. France Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 37. U.K. Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 38. Italy Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 39. Russia Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Discovery Biology Service Revenue YoY (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Top 8 Players Discovery Biology Service Revenue (US$ Million) in 2024

Figure 42. Asia-Pacific Discovery Biology Service Revenue (US$ Million) by Type (2020-2031)

Figure 43. Asia-Pacific Discovery Biology Service Revenue (US$ Million) by Application (2020-2031)

Figure 44. Indonesia Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 45. Japan Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 46. South Korea Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 47. Australia Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 48. India Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 49. Indonesia Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 50. Vietnam Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 51. Malaysia Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 52. Philippines Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 53. Singapore Discovery Biology Service Revenue (2020-2031) & (US$ Million)

Figure 54. Central and South America Discovery Biology Service Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Central and South America Top 5 Players Discovery Biology Service Revenue (US$ Million) in 2024

Figure 56. Central and South America Discovery Biology Service Revenue (US$ Million) by Type (2020-2031)

Figure 57. Central and South America Discovery Biology Service Revenue (US$ Million) by Application (2020-2031)

Figure 58. Brazil Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 59. Argentina Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 60. Middle East and Africa Discovery Biology Service Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Top 5 Players Discovery Biology Service Revenue (US$ Million) in 2024

Figure 62. South America Discovery Biology Service Revenue (US$ Million) by Type (2020-2031)

Figure 63. Middle East and Africa Discovery Biology Service Revenue (US$ Million) by Application (2020-2031)

Figure 64. GCC Countries Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 65. Israel Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 66. Egypt Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 67. South Africa Discovery Biology Service Revenue (2020-2025) & (US$ Million)

Figure 68. Discovery Biology Service Industry Chain Mapping

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions